Vericel (VCEL) Gross Margin (2011 - 2026)

Vericel's (VCEL) quarterly Gross Margin came in at 72.0% in Q1 2026, up 304.0% year-on-year from 17.82% in Q1 2025, and down 8.52% quarter-over-quarter from 78.7% in Q4 2025.

Vericel (VCEL) Gross Margin (2011 - 2026) Analysis & Trends

Vericel has disclosed Gross Margin across 16 years of filings, most recently posting 72.0% for Q1 2026.

  • Gross Margin for Q1 2026 came in at 72.0%, up 304.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 74.84% (up 230.0% YoY), and the FY2025 annual result was 74.42%, up 187.0% from the prior year.
  • Gross Margin came in at 72.0% for Q1 2026 at Vericel, down from 78.7% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 78.7% in Q4 2025 to a low of 61.69% in Q2 2022.
  • The 5-year median for Gross Margin is 69.5% (2024), against an average of 70.09%.
  • Across the five-year window, Gross Margin sank 640 bps in 2022 and soared 478 bps in 2024, its largest moves.
  • Vericel's Gross Margin stood at 72.59% in 2022, then rose by 3 bps to 74.63% in 2023, then rose by 4 bps to 77.61% in 2024, then advanced by 1 bps to 78.7% in 2025, then fell by 9 bps to 72.0% in 2026.
  • The last three Gross Margin figures came in at 72.0% (Q1 2026), 78.7% (Q4 2025), and 73.46% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 72.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 72.00%
Dec 31, 2025 78.70%
Sep 30, 2025 73.46%
Jun 30, 2025 73.71%
Mar 31, 2025 68.96%
Dec 31, 2024 77.61%
Sep 30, 2024 71.93%
Jun 30, 2024 69.50%
Mar 31, 2024 68.94%
Dec 31, 2023 74.63%
Sep 30, 2023 67.15%
Jun 30, 2023 65.20%
Mar 31, 2023 64.66%
Dec 31, 2022 72.59%
Sep 30, 2022 65.45%
Jun 30, 2022 61.69%
Mar 31, 2022 65.41%
Dec 31, 2021 71.51%
Sep 30, 2021 64.04%
Jun 30, 2021 68.09%